CL2020003277A1 - Métodos de fabricación de composiciones de aminoácidos - Google Patents

Métodos de fabricación de composiciones de aminoácidos

Info

Publication number
CL2020003277A1
CL2020003277A1 CL2020003277A CL2020003277A CL2020003277A1 CL 2020003277 A1 CL2020003277 A1 CL 2020003277A1 CL 2020003277 A CL2020003277 A CL 2020003277A CL 2020003277 A CL2020003277 A CL 2020003277A CL 2020003277 A1 CL2020003277 A1 CL 2020003277A1
Authority
CL
Chile
Prior art keywords
methods
amino acid
acid compositions
manufacturing amino
manufacturing
Prior art date
Application number
CL2020003277A
Other languages
English (en)
Inventor
Thomas Hanlon
Ralph Yamamoto
Denise K Kwok
Daniel Rothenberg
Andrew M Wood
Original Assignee
Axcella Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axcella Health Inc filed Critical Axcella Health Inc
Publication of CL2020003277A1 publication Critical patent/CL2020003277A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La presente divulgación proporciona métodos de fabricación de preparaciones mezcladas a gran escala que comprenden uno o más aminoácidos en donde las preparaciones tienen ciertas propiedades.
CL2020003277A 2018-06-20 2020-12-17 Métodos de fabricación de composiciones de aminoácidos CL2020003277A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201862687725P 2018-06-20 2018-06-20

Publications (1)

Publication Number Publication Date
CL2020003277A1 true CL2020003277A1 (es) 2021-07-09

Family

ID=67226342

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2020003277A CL2020003277A1 (es) 2018-06-20 2020-12-17 Métodos de fabricación de composiciones de aminoácidos

Country Status (17)

Country Link
US (1) US11679089B2 (es)
EP (1) EP3810168A1 (es)
JP (1) JP2021529735A (es)
KR (1) KR20210023846A (es)
CN (1) CN112823018A (es)
AR (1) AR115581A1 (es)
AU (1) AU2019288371A1 (es)
BR (1) BR112020025831A2 (es)
CA (1) CA3099762A1 (es)
CL (1) CL2020003277A1 (es)
IL (1) IL279328A (es)
JO (1) JOP20200323A1 (es)
MA (1) MA52957A (es)
MX (1) MX2020013732A (es)
SG (1) SG11202011611XA (es)
TW (1) TW202015668A (es)
WO (1) WO2019246201A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
JP2020517703A (ja) 2017-04-28 2020-06-18 アクセラ・ヘルス・インコーポレイテッドＡｘｃｅｌｌａ Ｈｅａｌｔｈ Ｉｎｃ． アミノ酸組成物及び外傷性脳損傷の治療のためのそれらの使用
CN111295187A (zh) 2017-08-14 2020-06-16 胺细拉健康公司 用于治疗肝脏疾病的氨基酸组合物
CU20200106A7 (es) 2018-06-20 2021-08-06 Axcella Health Inc Composiciones y métodos para el tratamiento de hemoglobinopatías y talasemias
SG11202011611XA (en) 2018-06-20 2021-01-28 Axcella Health Inc Methods of manufacturing amino acid compositions
EP3810123A1 (en) 2018-06-20 2021-04-28 Axcella Health Inc. Compositions and methods for the treatment of fat infiltration in muscle
EP4376826A1 (en) 2021-07-26 2024-06-05 Axcella (Assignment for the benefit of Creditors), LLC Amino acid compositions and methods for use in the treatment of post-acute sequelae of covid-19

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4871550A (en) * 1986-09-05 1989-10-03 Millman Phillip L Nutrient composition for athletes and method of making and using the same
EP0675725B1 (en) 1992-12-23 2002-01-30 Abbott Laboratories Medical foods for the nutritional support of infant/toddler metabolic diseases
US5922766A (en) * 1997-07-02 1999-07-13 Acosta; Phyllis J. B. Palatable elemental medical food
EP0891719A1 (en) 1997-07-14 1999-01-20 N.V. Nutricia Nutritional composition containing methionine
US20010041187A1 (en) 1998-10-20 2001-11-15 Carl W Hastings Performance-enhancing dietary supplement
WO2003041698A1 (fr) * 2001-11-13 2003-05-22 Kyowa Hakko Kogyo Co., Ltd. Comprimes contenant des acides amines se desintegrant rapidement dans la cavite buccale et procede de fabrication de ces comprimes
DK1511761T3 (da) 2003-04-07 2006-11-27 Novetide Ltd Fremgangsmåde til fremstilling af cykliske peptider
US20040213838A1 (en) 2003-04-24 2004-10-28 Mazer Terrence B. Medical food tablets containing free amino acids
US20070141150A1 (en) 2003-12-30 2007-06-21 Raghupathi Kandarapu Pharmaceutical composition
US20060073254A1 (en) 2004-10-04 2006-04-06 Steve Catani No-carb tabletop sweeteners substitute
WO2006062238A1 (ja) 2004-12-07 2006-06-15 Ajinomoto Co., Inc. アミノ酸の微粉末及びその懸濁液
US20070286909A1 (en) * 2006-06-07 2007-12-13 Daniel S. Smith Amino acid compositions
WO2011043647A1 (en) * 2009-10-09 2011-04-14 N.V. Nutricia Amino acid composition with improved dispersibility
JP2012136492A (ja) 2010-12-25 2012-07-19 Shiga Prefecture Seiyaku Kk 服用感を改善された漢方内服液剤
WO2015002527A1 (en) * 2013-07-05 2015-01-08 N.V. Nutricia Amino acid composition for use in the treatment of a pdd
WO2015015149A1 (en) 2013-07-31 2015-02-05 Leeds Metropolitan University Dietary supplement
EP3048904A2 (en) 2013-09-25 2016-08-03 Pronutria Biosciences, Inc. Compositions and formulations for treatment of gastrointestinal tract malabsorption diseases and inflammatory conditions and methods of production and use thereof
US20180125926A1 (en) 2013-09-25 2018-05-10 Axcella Health Inc. Compositions and Formulations and Methods of Production and Use Thereof
FR3032883B1 (fr) * 2015-02-24 2017-03-17 International Nutrition Res Company Composition pour la prevention et le traitement de la steatose et de la steatohepatite metaboliques
JO3543B1 (ar) * 2015-09-28 2020-07-05 Applied Pharma Res تراكيب حمض أميني إصدار معدل تعطى عن طريق الفم
SI3411047T1 (sl) * 2016-02-04 2021-09-30 Czap Research And Development, Llc Sredstva za nadzorovano sproščeni in stratificirani kompleks vključitve ciklodekstrina
PL238958B1 (pl) 2016-06-29 2021-10-25 Olimp Laboratories Spolka Z Ograniczona Odpowiedzialnoscia Kompozycja aminokwasowa do stosowania przed wysiłkiem fizycznym
US20180015122A1 (en) * 2016-07-14 2018-01-18 Companion Supplements, LLC Pharmaceutical composition effective in preventing adverse effects associated with the use of glucocorticoids
JOP20190147A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض واضطرابات العضلات
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
JP2018154598A (ja) 2017-03-21 2018-10-04 株式会社明治 アミノ酸含有顆粒およびその製造方法
JP2020517703A (ja) 2017-04-28 2020-06-18 アクセラ・ヘルス・インコーポレイテッドＡｘｃｅｌｌａ Ｈｅａｌｔｈ Ｉｎｃ． アミノ酸組成物及び外傷性脳損傷の治療のためのそれらの使用
CN111295187A (zh) 2017-08-14 2020-06-16 胺细拉健康公司 用于治疗肝脏疾病的氨基酸组合物
MX2020001766A (es) 2017-08-14 2020-07-29 Axcella Health Inc Composiciones de aminoacidos para el tratamiento de lesion neuronal.
CN112689504A (zh) 2018-06-20 2021-04-20 胺细拉健康公司 含有苦味氨基酸的治疗和保健组合物
AR115583A1 (es) 2018-06-20 2021-02-03 Axcella Health Inc Composiciones y métodos para el tratamiento de las enfermedades y trastornos del hígado
WO2019246299A1 (en) 2018-06-20 2019-12-26 Axcella Health Inc. Compositions and methods for the reduction or treatment of insulin resistance and metabolic conditions
US20210275480A1 (en) 2018-06-20 2021-09-09 Axcella Health Inc. Compositions and methods for the reduction or treatment of fibrosis
CN112839712A (zh) 2018-06-20 2021-05-25 胺细拉健康公司 用于减少或治疗发炎的组合物和方法
SG11202011611XA (en) 2018-06-20 2021-01-28 Axcella Health Inc Methods of manufacturing amino acid compositions
EP3810123A1 (en) 2018-06-20 2021-04-28 Axcella Health Inc. Compositions and methods for the treatment of fat infiltration in muscle
CU20200106A7 (es) 2018-06-20 2021-08-06 Axcella Health Inc Composiciones y métodos para el tratamiento de hemoglobinopatías y talasemias

Also Published As

Publication number Publication date
JOP20200323A1 (ar) 2020-12-14
CA3099762A1 (en) 2019-12-26
EP3810168A1 (en) 2021-04-28
AR115581A1 (es) 2021-02-03
AU2019288371A1 (en) 2020-12-03
CN112823018A (zh) 2021-05-18
MA52957A (fr) 2021-04-28
IL279328A (en) 2021-01-31
BR112020025831A2 (pt) 2021-03-23
JP2021529735A (ja) 2021-11-04
TW202015668A (zh) 2020-05-01
MX2020013732A (es) 2021-02-26
WO2019246201A1 (en) 2019-12-26
US20190388374A1 (en) 2019-12-26
US11679089B2 (en) 2023-06-20
SG11202011611XA (en) 2021-01-28
KR20210023846A (ko) 2021-03-04

Similar Documents

Publication Publication Date Title
CL2020003277A1 (es) Métodos de fabricación de composiciones de aminoácidos
CO2021003036A2 (es) Compuestos de anillo fusionado
CU20190058A7 (es) Composiciones de aminoácidos relacionadas con mejoras de la función hepática
CO2021005987A2 (es) Compuestos de anillo fusionado
CL2021001179A1 (es) Anticuerpos específicos para tl1a y ácidos nucleicos que los codifican (divisional de la solicitud no. 201801596).
BR112019004998A2 (pt) anticorpos anti-pd-1(cd279)
BR112019000195A2 (pt) composições e métodos relacionados a sistemas celulares terapêuticos que expressam rna exógeno
CL2017002066A1 (es) Proteasas de cisteína
CU20190057A7 (es) Composiciones que comprenden aminoácidos
BR112018074468A2 (pt) anticorpos anti-cd40 e suas utilizações
BR112018010381A2 (pt) composições para tratamento de cabelo, condicionadora de cabelo e para alteração da cor do cabelo, sistema para tratamento de cabelo, métodos para tratamento de cabelo e para alteração da cor do cabelo, e, kit de multicompartimentos.
BR112018068341A2 (pt) 6-hidróxi-4-oxo-1,4-di-hidropirimidina-5-carboxamidas como agonistas de apj
GT201700184A (es) Nuevas proteínas específicas para pioverdina y pioquelina
CY1124521T1 (el) Σκευασματα αντισωματος anti-cd19
BR112019001980A2 (pt) inibidor de ido1 e método de preparação e aplicação do mesmo
BR112021025438A2 (pt) Composições de proteínas anti-vegf e métodos para produzir as mesmas
BR112016024494A8 (pt) análogo de peptídeo e seu uso
CL2019002605A1 (es) Formulaciones que contienen proteínas de unión pd-1 y métodos de fabricación de las mismas.
BR112017006602A2 (pt) método de conjugação de um polipeptídeo
BR112018010357A2 (pt) composições para tratamento de cabelo, condicionadora de cabelo e alteradora da cor do cabelo, sistema para tratamento de cabelo, métodos para tratamento do cabelo e para alteração da cor do cabelo, e, kit de multicompartimentos.
DOP2017000193A (es) Composición ácida a base de leonardita y aminoácidos
BR112018012304A2 (pt) composições e métodos para diminuir expressão de tau
ECSP17074919A (es) Piroglutamato de vortioxetina
BR112019000135A2 (pt) formulações de anticorpo
BR112021011124A2 (pt) Anelossomos e métodos de uso